Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Cynthia Rudin, PhD, is a highly regarded computer scientist who’s been eyeing the advance of artificial intelligence into society with equal parts enthusiasm and concern.
By now it’s a difficult-to-dispute likelihood: AI won’t replace doctors making diagnoses, but doctors who use AI will displace doctors who don’t use AI. The hypothesis gets a fresh airing out from the vantage point of the general public.
As younger patients grow up using smartphones and the internet, some may become addicted to the technology and develop imbalances in brain chemistry, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA) in Chicago.
Older patients are mostly accepting of wearable activity trackers and understand the value the device could have in improving their health, according to a study published in JMIR mHealth and uHealth.
The U.S. Food and Drug Administration today approved the FoundationOne CDx (F1CDx), the first breakthrough-designated, next generation sequencing (NGS)-based in vitro diagnostic (IVD) test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type. The Centers for Medicare & Medicaid Services (CMS) at the same time proposed coverage of the F1CDx. The test is the second IVD to be approved and covered after overlapping review by the FDA and CMS under the Parallel Review Program, which facilitates earlier access to innovative medical technologies for Medicare beneficiaries.
Patients with diabetes were able to decrease their hemoglobin A1c by an average of 1.36 percent using One Drop Mobile applications on iPhones and Apple Watches, according to a study published in JMIR mHealth & uHealth.
AliveCor, developers of electrocardiogram (ECG) technology, have received clearance from the U.S. Food and Drug Administration (FDA) for the KardiaBand, an accessory that will allow Apple Watch users to view ECGs at any time.
Accurate Neuromonitoring, a leading Intraoperative Neuromonitoring (IONM) provider offering functional guidance to surgeons through the use of electrophysiological methods that help reduce patient risk, has acquired Atlanta, Georgia-based NeuroLink Monitoring, expanding its coverage to seven East Coast States -- New York, New Jersey, North Carolina, South Carolina, Georgia, Alabama, and Florida.
While biologic medications have revolutionized the treatment of chronic diseases and conditions, reports show approximately 50 percent of medications for chronic disease are not taken as prescribed. It’s a situation that providers, payers and pharmaceutical companies are trying to change, and a breakthrough needle-free drug delivery system from Portal Instruments that uses technology out of MIT to allow patients to easily manage their chronic conditions at home could help.
A small-town physician in New London, New Hampshire, will not regain her license after it was surrendered in October. The state questioned Anna Konopka's ability to keep records, make decisions and prescribe medication because the 84-year-old does not have and is unable to use a computer.
U.S. health systems are increasingly leveraging digital health to conduct their operations, but how health systems are using digital health in their strategies can vary widely.
When human counselors are unavailable to provide work-based wellness coaching, robots can substitute—as long as the workers are comfortable with emerging technologies and the machines aren’t overly humanlike.
A vendor that supplies EHR software to public health agencies is partnering with a health-tech startup in the cloud-communications space to equip state and local governments for managing their response to the COVID-19 crisis.
